MicroConstants Blog Determining Immunogenicity for CAR-T cell Therapies

Chimeric Antigen Receptor (CAR)-T cell therapy is a novel cancer therapy that harnesses and redirects the cytotoxic activity of T cells against cancer cells. CAR-T cells are generated by engineering T cells to express a chimeric antigen receptor, which is typically an antibody directed against a target on the cancer cell, fused with TCR signaling [...]Share ThisThe post Determining Immunogenicity for CAR-T cell Therapies appeared first on Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis.